Welcome to KenricoCare. KenricoCare has been provided since 1985 and is supported by Kenrico medical doctors. We are priviledged to answer any of your health-related questions and will help you with our suggestions based on our expertise. Please refer to the posting guidelines below before you post your question.

Re(1): Malignant Brain Tumor

Posted on August 20, 2007 at 03:38:21 AM by KenricoCare
Hi there,

The best suitable products for your son is the gold edition pads (TRMX-2), green edition pads (KX-2), and the special edition pads or popularly known as green tea pads (CC). Our TRMX-2 and KX-2 have been frequently used to assist the therapies with high success rate.

GBM is the most common and aggressive type of primary brain tumor, accounting for 52% of all primary brain tumor cases and 20% of all intracranial tumors. The rate of tumor reoccurence after surgery is also quite high, using the green tea pads (CC) more frequently is strongly recommended.

Our recommendation of the usage schedule is below. You can also consult to your physician and ask them to include TRMX-2, KX-2, and CC into the therapy programs.

Monday: CC
Tuesday: CC
Wednesday: CC
Thursday: TRMX-2 and/or KX-2
Friday: TRMX-2 and/or KX-2
Saturday: CC
Sunday: CC

In health,
Kenrico Support

Thread overview

  • Malignant Brain Tumor - By Mrs. Shanker August 16, 2007 at 07:40:59 AM
    • Re(1): Malignant Brain Tumor - By KenricoCare August 20, 2007 at 03:38:21 AM

Posting a reply disabled

You can't reply to this message because this message is too old.

KenricoCare is developed to meet the requirement of CE & ISO 9001:2018 Quality Management System. Visit the Distributors page for Distributorship information. KenricoCare is for medical support and consultation only, meaning that we do not allow posting of brand names, website links, or inflammatory post. A VALID email address is required to post. We reserve the right to edit or delete posts that do not follow our posting guidelines. Further posting of deleted posts will cause you banned permanently.